The Johns Hopkins Kimmel Cancer Center, Sibley Memorial Hospital and Suburban Hospital are ushering in a new era of cancer medicine. Progress that could not even be imagined a decade ago is now being realized. We are transforming cancer medicine away from a model in which we see patients for the first time when they begin experiencing symptoms to one that detects, manages, and many times eradicates cancers before patients even know they have them. This work is being driven by our pioneering discoveries in cancer genetics and epigenetics.
We are leading the way in developing tests that detect cellular alterations that identify cancers, predict which therapies a cancer will respond to, and monitors cancers for recurrence. We are beginning to use our scientific discoveries to determine which treatments and screening interventions will work best for each patient, and just as importantly, we are using this new knowledge to spare patients the risk and adverse affects of treatments that will not work.
We are uniquely positioned to make revolutionary advances against cancer. Our scientists have led the world in deciphering the genetic and epigenetic cause of cancer, and now our scientists are developing the technologies that will allow these discoveries to be routinely used to make clinical decisions about how best to treat cancers, not just at Johns Hopkins, but also at cancer centers around the country and around the world.
- The name Johns Hopkins has become synonymous with excellence in research and patient care. Its science and medical programs earn more federal research dollars than any other medical institution in the country.
- Our Cancer Center has led the world in deciphering the mechanisms of cancer and new ways to treat it. The strength of our research and treatment programs was recognized early on by the National Cancer Institute, becoming one of the first to earn comprehensive cancer center status.
- One of only 40 cancer centers in the country designated by the National Cancer Institute (NCI) as a Comprehensive Cancer Center, the Johns Hopkins Kimmel Cancer Center has active programs in clinical research, laboratory research, education, community outreach, and prevention and control.
- Johns Hopkins’ pioneering research defined cancer as a genetic disease that, in turn, led to the first genetic tests for a hereditary cancer and a screening tool test for colon cancer. Kimmel Cancer Center researchers completed the first map of a cancer genome and were among the first to develop therapeutic cancer vaccines and to perform bone marrow transplants to treat blood and immune-forming cancers. But the expertise and commitment of our investigators is only part of the reason that Hopkins is a world leader in breakthrough discoveries related to cancer. The mission of the Kimmel Cancer Center is to go beyond the cutting edge in science and medicine to perform the most advanced research and translate the discoveries into the very best cancer therapies. The latest, plus some—is how Kimmel Cancer Center Director William Nelson describes this objective, pointing to state-of-the-art as just the starting point of what we offer.